-
Featured
Propensity Score Weighting Accounts Well for Placebo Response in Two Trials of Medical Therapy for MDD
Maurizio Fava, MD, and colleagues previously developed an AI approach to account for the propensity to respond to placebo in randomized, controlled trials of drugs for major depressive disorder (MDD), and they show the method more accurately interprets the results of trials complicated by the placebo response.
-
Featured
Multiple Intra-articular Steroid Hip Injections Bring Greater Infection Risk
Multiple intra-articular steroid hip injections versus one injection bring far greater risk of periprosthetic joint infections for total hip arthroplasty patients.
-
Radiology Research in a Rapidly Changing World
As the world changes rapidly, the Department of Radiology at Mass General continues to explore the impact on human health of a variety of concerns — including the aging population in the U.S., the epidemic of loneliness, the climate crisis, and more — and how imaging can mitigate the detrimental effects of the changes.
-
Brain Pathology Adds to Evidence of Link Between Social Activity and Preserved Cognition in Older Adults
Heidi I. L. Jacobs, PhD, and colleagues determined the greater density of tau tangles in the locus coeruleus may degrade cognition and social function independently of Alzheimer's disease pathology and before the onset of cognitive impairment. And that the amount of social activity can partially explain this.
-
Review: Cognitive Issues in Patients With IDH-mutant Gliomas
Michael W. Parsons, PhD, and David S. Sabsevitz, PhD, recently shared their expertise about how and why to integrate neuropsychological assessment into the preoperative care and long-term follow-up of patients with IDH-mutant glioma.
-
Chief of Psychiatry, Maurizio Fava, MD, Discusses U.S. News & World Report ranking Mass General #1 for Psychiatry in 2024-25
The Massachusetts General Hospital Department of Psychiatry has been recognized for its exceptional commitment to advancing mental healthcare. Mass General was ranked #1 Psychiatry in the nation for Psychiatry in 2024-25 by U.S. News and World Report.
Psychiatry Contributors
-
David Mischoulon, MD, PhD
Director, Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Joyce R. Tedlow Professor of Psychiatry, Harvard Medical School
Recent Article
Heated Yoga Linked to Reduction of Moderate to Severe Depressive Symptoms in Randomized Controlled Trial
-
Eve Valera, PhD
Researcher, Athinoula A. Martinos Center for Biomedical Imaging
Recent Article
Q&A: Dr. Eve Valera on Intimate Partner Violence and Brain Injury
-
Jodi Gilman, PhD
Director of Neuroscience, Center for Addiction Medicine, Massachusetts General Hospital
Recent Article
Pain Catastrophizing Is Associated With Reduced Neural Response to Monetary Reward
-
Jordan W. Smoller, MD, ScD
Associate Chief for Research, Department of Psychiatry, Massachusetts General Hospital, Director, Psychiatric and Neurodevelopmental Genetics Unit, Professor of Psychiatry at Harvard Medical School and Professor in the Department of Epidemiology at the Harvard School of Public Health
Recent Article
Psychiatric Disorders Not Associated With Incidental Findings in Medically Actionable Genes
-
Maurizio Fava, MD
Psychiatrist-In-Chief; Director, Division of Clinical Research of the MGH Research Institute, Executive Director, Clinical Trials Network and Institute (CTNI), Massachusetts General Hospital, Associate Dean for Clinical & Translational Research, Slater Family Professor of Psychiatry, Harvard Medical School
Recent Article
Propensity Score Weighting Accounts Well for Placebo Response in Two Trials of Medical Therapy for MDD
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.